West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 676.70 M

West Pharmaceutical Services, Inc. Operating Cash Flow is USD 676.70 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -10.06% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 752.40 M, a 6.42% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 707.00 M, a 4.71% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 675.20 M, a 34.93% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 500.40 M, a 19.23% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities